Partnership for Research on Ebola VACcination (PREVAC): protocol of a randomized, double-blind, placebo-controlled phase 2 clinical trial evaluating three vaccine strategies against Ebola in healthy volunteers in four West African countries
DiscussionThe PREVAC trial is evaluating —placebo-controlled—two promising Ebola candidate vaccines in advanced stages of development. The results will address unanswered questions related to short- and long-term safety and immunogenicity for three vaccine strategies in adults and children.Trial registrationClinicalTrials.govNCT02876328. Registered on 23 August 2016. (Source: Trials)
Source: Trials - January 23, 2021 Category: Research Source Type: clinical trials
A Study of a 2-dose Ebola Vaccine Regimen of Ad26.ZEBOV Followed by MVA-BN-Filo in Healthy Pregnant Women
Condition: Healthy Interventions: Biological: Ad26.ZEBOV; Biological: MVA-BN-Filo Sponsors: Janssen Vaccines & Prevention B.V.; Center for Family Health Research (CFHR); Coalition for Epidemic Preparedness Innovations (CEPI); Emory University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 21, 2020 Category: Research Source Type: clinical trials
